BioLineRx Announces Notice of Allowance from USPTO for Patent Covering Motixafortide (BL-8040) in Combination With Anti-PD-1 for the Treatment of Any Type of Cancer

Stock Information for BioLineRx Ltd.

Loading

Please wait while we load your information from QuoteMedia.